CJ-12406
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CJ-12406, covering 2012-08-02 to 2012-08-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of CJ-12406 in Healthy Male Subjects [Phase 1]